Stimdia Medical Inc. Initiates FDA Approved IDE Pivotal Trial to Investigate Impact of Neuromuscular Stimulation on Mechanically Ventilated Patients by larryyost | Oct 3, 2023 | Press Release
Stimdia Medical Announces Close of Series B Equity Financing Round with Proceeds to be Used to Complete the Company’s Pivotal Study by larryyost | Jul 12, 2022 | Press Release
Stimdia Medical Receives FDA Breakthrough Device Designation for the pdSTIM™ System Designed to Facilitate Weaning Patients from Mechanical Ventilation by larryyost | Mar 18, 2021 | Press Release